elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q43940290-16B2B8BE-D1D2-43C2-AC28-46645A448BA9
Q43940290-16B2B8BE-D1D2-43C2-AC28-46645A448BA9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43940290-16B2B8BE-D1D2-43C2-AC28-46645A448BA9
Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP.
P2860
Q43940290-16B2B8BE-D1D2-43C2-AC28-46645A448BA9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43940290-16B2B8BE-D1D2-43C2-AC28-46645A448BA9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b0cb77d128e9855b8deecfc8667d0516272726a1
P2860
Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.